Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Biologics Market Report 2020-2030: Forecast by Product Type, by Application, by Manufacturing, Geography, plus Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios

Published by Visiongain Ltd Product code 962999
Published Content info 713 Pages
Delivery time: 1-2 business days
Price
Back to Top
Biologics Market Report 2020-2030: Forecast by Product Type, by Application, by Manufacturing, Geography, plus Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios
Published: August 4, 2020 Content info: 713 Pages
Description

Title:
Biologics Market Report 2020-2030
Forecast by Product Type (Monoclonal Antibodies (Humira, Remicide, Tysabri, Herceptin, Kadcyla, Perjeta, Opdivo, Keytruda, Avastin), Vaccines, Protein Therapeutics (Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulation Factors, Interferons, Enzyme Replacement & Other Protein Therapies), Regenerative Medicines (Stem Cell Therapy, Tissue Engineered Products, Gene Therapies), Fusion Proteins), by Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Disorders, Haematological Disorders, Others), by Manufacturing (Outsourced, In-house), and Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) PLUS Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios.

Biologics-our new study reveals trends, R&D progress, and predicted revenues

Where is the Biologics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 710+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biologics Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT, Porter's, PEST Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

By Product Type

Monoclonal Antibodies

  • Humira
  • Remicide
  • Tysabri
  • Herceptin
  • Kadcyla
  • Perjeta
  • Opdivo
  • Keytruda
  • Avastin

Vaccines

Protein Therapeutics

  • Insulin:
    • Lantus
    • Novolog/NovoRapid
    • Humalog
    • Levemir
    • Apidra
  • Other Recombinant Hormones
  • Plasma & Recombinant Coagulation Factors
  • Interferons:
    • Avonex
    • Rebif
  • Enzyme Replacement & Other Protein Therapies

Regenerative Medicines

  • Stem Cell Therapy:
    • Osteocel Plus
    • Trinity Evolution & Trinity Elite
  • Tissue Engineered Products:
    • Apligraft
    • Demagraft
  • Gene Therapies (IMIGYLC)

Fusion Proteins

  • Enbrel
  • Eylea

By Application

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Disorders
  • Haematological Disorders
  • Others

By Manufacturing

  • Outsourced
  • In-house

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Biologics Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biologics Market report helps you

In summary, our 710+ page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Biologics Market, with forecasts for Product Type, Application and Manufacturing, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 16 key national markets - See forecasts for the Biologics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, GCC Countries and South Africa.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 23 of the major companies involved in the Biologics Market. Some of the company's profiles in this report include GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi S.A., Novo Nordisk A/S, Takeda Pharmaceutical, Gilead Sciences, Regeneron Pharmaceuticals, Inc., Biogen, AbbVie, and Amgen among other prominent players

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biologics Market and leading companies. You will find data, trends and predictions.

Buy our report today Biologics Market Report 2020-2030: Forecast by Product Type (Monoclonal Antibodies (Humira, Remicide, Tysabri, Herceptin, Kadcyla, Perjeta, Opdivo, Keytruda, Avastin), Vaccines, Protein Therapeutics (Insulin, Other Recombinant Hormones, Plasma & Recombinant Coagulation Factors, Interferons, Enzyme Replacement & Other Protein Therapies), Regenerative Medicines (Stem Cell Therapy, Tissue Engineered Products, Gene Therapies), Fusion Proteins), by Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Disorders, Haematological Disorders, Others), by Manufacturing (Outsourced, In-house), and Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) PLUS Profiles of Leading Biologics Companies and COVID-19 Impact Scenarios. Avoid missing out by staying informed - order our report now.

Table of Contents
Product Code: PHA0790

Table of Contents

1. Report Overview

  • 1.1 Introduction to Biologics Market
  • 1.1. Global Biologics Market Segmentation
  • 1.2 Biologics Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
      • 1.7.1.1 Impact of COVID 19 on Global Pharma Supply Chain
      • 1.7.1.2 Worldwide air transportation availability and costs
      • 1.7.1.3 Return of pharmaceutical manufacturing back to the US
      • 1.7.1.4 Possible supply disruptions of drugs identified as potential treatments against COVID-19
      • 1.7.1.5 Prescription refills
      • 1.7.1.6 Impact of pharmaceutical companies in clinical need
      • 1.7.1.7 Battle for cure
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Market Size Estimation
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Drivers
    • 3.1.1 Ability to command high prices
    • 3.1.2 Aging population and the rise of chronic disease
    • 3.1.3 Product launches will drive biologics market
    • 3.1.4 Rise in prevalence of chronic diseases
  • 3.2 Restraints
    • 3.2.1 Difficulty in manufacturing biologics
    • 3.2.2 Stringent regulatory process and high capital investment
    • 3.2.3 High costs in the face of declining national healthcare budgets
  • 3.3 Opportunities
    • 3.3.1 Application of biologics in complex diseases
    • 3.3.2 Rising demand for next generation biologics
    • 3.3.3 Consolidation growing in the industry
    • 3.3.4 Pleasant policy controls
    • 3.3.5 Strong pipeline of biologics drugs
  • 3.4 Challenges
    • 3.4.1 Risk and damage to supply chain due to COVID-19
    • 3.4.2 Development of promising biological molecule into an effective product
    • 3.4.3 Biosimilars - both an opportunity and a threat
  • 3.5 Trends
    • 3.5.1 Growing strategic partnerships in China
    • 3.5.2 Outsourcing strategies
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 Competitive Rivalry - High
    • 3.6.2 Threat of New Entrants - Low
    • 3.6.3 Bargaining Power of Suppliers - Low
    • 3.6.4 Bargaining Power of Buyers - Medium
    • 3.6.5 Threat of Substitutes - Medium/Low
  • 3.7 SWOT Analysis
    • 3.7.1 Strengths
    • 3.7.2 Weaknesses
    • 3.7.3 Opportunities
    • 3.7.4 Threats
  • 3.8 PEST Analysis
    • 3.8.1 Political
    • 3.8.2 Economical
    • 3.8.3 Social
    • 3.8.4 Technological

4 Global Biologics Market Size Forecast 2020-2030 by Product Type

  • 4.1 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030
    • 4.1.1 Monoclonal Antibodies Sub-market: Scientific and Historical Background
      • 4.1.1.1 Natural Antibodies: Key to the Immune System
      • 4.1.1.2 From serum therapy to monoclonal antibodies
      • 4.1.1.3 Humanising the mAb
      • 4.1.1.4 MAbs have found success in treating autoimmune disorders, cancers and other diseases - Great potential for the future
      • 4.1.1.5 MAbs for All? Technologies Come Off Patent
    • 4.1.2 Global Biologics Market for Monoclonal Antibodies Segment: Recovery Forecasts (V,U, W, L)
    • 4.1.3 Autoimmune mAbs
      • 4.1.3.1 Humira - The World's Best-Selling Prescription Drug
        • 4.1.3.1.1 Expanded Indications for Humira
        • 4.1.3.1.2 Biosimilar Adalimumab: Patents Protect Humira in Developed Markets for Now
    • 4.1.4 Global Biologics Market for Humira Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.4.1 Remicade: A Treatment for Immune-mediated Inflammatory Diseases
        • 4.1.4.1.1 Patent Dance in the US
        • 4.1.4.1.2 Biosimilar Infliximab: Multiple Launches
    • 4.1.5 Global Biologics Market for Remicade Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.5.1 Tysabri: Blockbuster Drug's High Efficacy Offsets its Risks
    • 4.1.6 Global Biologics Market for Tysabri Segment: Recovery Forecasts (V,U, W, L)
    • 4.1.7 Oncology mAbs
      • 4.1.7.1 Past Approvals
      • 4.1.7.2 Rising Incidence of Cancer Will Drive Demand
      • 4.1.7.3 Rituxan: The World's Leading Anti-Cancer mAb
      • 4.1.7.4 Biosimilar Rituximab: Two Candidates Await Approval in Europe
      • 4.1.7.5 Avastin: Growing under CER, Through New Indications
        • 4.1.7.5.1 Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA
        • 4.1.7.5.2 Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for Roche, Although Various Biosimilars in Development
    • 4.1.8 Global Biologics Market for Avastin Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.8.1 Herceptin: Breast Cancer Blockbuster
        • 4.1.8.1.1 Pricing Challenges in Emerging Markets
        • 4.1.8.1.2 Roche Builds Franchise of Anti-HER2 mAbs Around Herceptin
        • 4.1.8.1.3 Biosimilar Trastuzumab
    • 4.1.9 Global Biologics Market for Herceptin Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.9.1 Kadcyla
        • 4.1.9.1.1 Mixed Results from Different Clinical Trials
        • 4.1.9.1.2 Kadcyla Sales Forecast 2020 -2030
    • 4.1.10 Global Biologics Market for Kadcyla Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.10.1 Perjeta
        • 4.1.10.1.1 Positive Results from Different Clinical Trials
    • 4.1.11 Global Biologics Market for Perjeta Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.11.1 Opdivo: Big Potential for Bristol-Myer Squibb's PD-1 Inhibitor
    • 4.1.12 Global Biologics Market for Opdivo Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.12.1 Keytruda
    • 4.1.13 Global Biologics Market for Keytruda Segment: Recovery Forecasts (V,U, W, L)
      • 4.1.13.1.1 Good News and Bad News for NSCLC from CheckMate Trials
      • 4.1.13.1.2 Cyramza (Eli Lilly): Approved in Three Additional Indications Since its First Approval in April 2014.
      • 4.1.13.2 Oncology mAbs: New Approvals and Pipeline
        • 4.1.13.2.1 Empliciti (Elotuzumab) by Bristol-Myers Squibb and AbbVie): Recently Approved
        • 4.1.13.2.2 Unituxin (United Therapeutics) Receives FDA Approval March 2015
        • 4.1.13.2.3 SAR3419 (coltuximab ravtansine) (anti-CD19, Sanofi)
  • 4.2 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030
    • 4.2.1 Global Biologics Market for Vaccines Segment: Recovery Forecasts (V,U, W, L)
  • 4.3 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030
    • 4.3.1 Global Biologics Market for Protein Therapeutics Segment: Recovery Forecasts (V,U, W, L)
    • 4.3.2 Global Biologics Market for Insulin Sub Segment: Revenue Forecast 2020-2030
    • 4.3.3 Global Biologics Market for Insulin Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.3.1 Lantus
    • 4.3.4 Global Biologics Market for Lantus Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.4.1 NovoLog/NovoRapid
    • 4.3.5 Global Biologics Market for Novolog Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.5.1 Humalog
    • 4.3.6 Global Biologics Market for Humalog Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.6.1 Levemir
    • 4.3.7 Global Biologics Market for Levemir Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.7.1 Apidra
    • 4.3.8 Global Biologics Market for Apidra Segment: Recovery Forecasts (V,U, W, L)
    • 4.3.9 Other Recombinant Hormones: Erythropoietins, G-CSF and Human Growth Hormone
    • 4.3.10 Global Biologics Market for Other Recombinant Hormones Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.10.1 Erythropoietin
      • 4.3.10.2 G-CSF
      • 4.3.10.3 Human Growth Hormones
      • 4.3.10.4 Plasma and Recombinant Coagulating Factors
    • 4.3.11 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.11.1 Interferons
    • 4.3.12 Global Biologics Market for Interferons Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.12.1.1 Avonex
    • 4.3.13 Global Biologics Market for Avonex Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.13.1.1 Rebif
    • 4.3.14 Global Biologics Market for Rebif Segment: Recovery Forecasts (V,U, W, L)
      • 4.3.14.1.1 Betaseron
      • 4.3.14.1.2 Plegridy
      • 4.3.14.2 Enzyme Replacement and Other Protein Therapies
    • 4.3.15 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Recovery Forecasts (V,U, W, L)
  • 4.4 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030
    • 4.4.1 Global Biologics Market for Regenerative Medicines Segment: Recovery Forecasts (V,U, W, L)
    • 4.4.2 Stem Cell Therapies
      • 4.4.2.1 Stem Cells: Scientific Breakdown
    • 4.4.3 Stem Cell Therapies
      • 4.4.3.1 Haematopoietic Stem Cell Transplantation:
      • 4.4.3.2 From Procedures to Products: Cord Blood Stem Cell Approvals
    • 4.4.4 Global Biologics Market for Stem Cell Therapy Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.4.1 Osteocel Plus: The Leading Stem Cell Orthobiologic
    • 4.4.5 Global Biologics Market for Osteocel Plus Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.5.1 Trinity Evolution and Trinity Elite
        • 4.4.5.1.1 Trinity Evolution and Trinity Elite Revenue Forecast to 2030
    • 4.4.6 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.6.1.1 MSC-100-IV (Previously Known as Prochymal): World's First Approved Stem Cell Drug Outside of South Korea
      • 4.4.6.1.2 An Important Role to Play in the Future of HSCT, and also Wins Approval in Japan through Partner
      • 4.4.6.1.3 CARTISTEM (MEDIPOST): The World's First Allogeneic Stem Cell Drug
      • 4.4.6.1.4 Hearticellgram-AMI (PharmaCell B.V.): One of the First Approved Cardiovascular Stem Cell Treatments in the World.
    • 4.4.7 Tissue Engineering Therapies
      • 4.4.7.1 Tissue Engineering - In Vitro Manipulation for Therapeutic Purposes
      • 4.4.7.2 Current Status of the Market
    • 4.4.8 Global Biologics Market for Tissue Engineered Products Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.8.1 Apligraf: The Leading Product
      • 4.4.8.2 Apligraf's role in Wound Healing
    • 4.4.9 Global Biologics Market for Dermagraft Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.9.1 ReCell
      • 4.4.9.2 MySkin and CyroSkin
    • 4.4.10 Global Biologics Market for Apligraft Segment: Recovery Forecasts (V,U, W, L)
      • 4.4.10.1 Dermagraft: Organogenesis Further Strengthens Position Through this 2014 Acquisition
    • 4.4.11 Tissue Engineering Therapies Pipeline
      • 4.4.11.1 NeoCart by Histogenics: Undergoing Phase 3 Trial for Knee Cartilage Repair
      • 4.4.11.2 Extracorporeal Bio-Artificial Liver Therapy by Vital Therapies
      • 4.4.11.3 StrataGraft by Stratatech Corporation Demonstrates Positive Top-Line Results
    • 4.4.12 Gene Therapies
      • 4.4.12.1 Gene Therapy: Historical and Scientific Background
      • 4.4.12.2 Harnessing Infectivity: Viral Vectors in Gene Therapy
      • 4.4.12.3 Approved Gene Therapy Products
        • 4.4.12.3.1 Gendicine: The World's First Commercial Gene Therapy Product
        • 4.4.12.3.2 Oncorine: First Oncolytic Viral Therapy
        • 4.4.12.3.3 Neovasculgen: Russia's First Gene Therapy
        • 4.4.12.3.4 Neovasculgen: Drop in Revenues in 2015, but HSCI Predicts Notable Increases as Product is Added to VED List
        • 4.4.12.3.5 Glybera: The First Gene Therapy for Western Markets, Although Has Abandoned Hope of Receiving FDA-Approval
      • 4.4.12.4 IMLYGIC
        • 4.4.12.4.1 IMLYGIC: Clinical Trials and Development Efforts
    • 4.4.13 Global Biologics Market for IMIGYLC Segment: Recovery Forecasts (V,U, W, L)
  • 4.5 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030
    • 4.5.1 Scientific and Historical Background
      • 4.5.1.1 Differentiating Fusion Proteins
    • 4.5.2 Global Biologics Market for Fusion Proteins Segment: Recovery Forecasts (V,U, W, L)
    • 4.5.3 Enbrel: The First FP to be Approved, in 1998
      • 4.5.3.1 Gradually Approved for Additional Indications
      • 4.5.3.2 Enbrel Granted Extended Patent Protection in the US, Patent has Expired in EU
      • 4.5.3.3 Multiple Biosimilars Available in Emerging Markets
    • 4.5.4 Global Biologics Market for Enbrel Segment: Recovery Forecasts (V,U, W, L)
    • 4.5.5 Eylea: Blockbuster FP Treatment for Wet AMD
    • 4.5.6 Global Biologics Market for Eylea Segment: Recovery Forecasts (V,U, W, L)
    • 4.5.7 Fusion Proteins Pipeline
      • 4.5.7.1 Sotatercept by Acceleron Pharma and Celgene Corporation - Currently Undergoing Eight Clinical Trials
      • 4.5.7.2 Blisibimod (Anthera Pharmaceuticals) for the Treatment of Various Autoimmune Diseases, in Late Stage Development

5 Global Biologics Market Size Forecast 2020-2030 by Application Type

  • 5.1 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030
    • 5.1.1 Global Biologics Market for Oncology Segment: Recovery Forecasts (V,U, W, L)
  • 5.2 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030
    • 5.2.1 Global Biologics Market for Autoimmune Diseases Segment: Recovery Forecasts (V,U, W, L)
  • 5.3 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030
    • 5.3.1 Global Biologics Market for Infectious Diseases Segment: Recovery Forecasts (V,U, W, L)
  • 5.4 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030
    • 5.4.1 Global Biologics Market for Cardiovascular Disorders Segment: Recovery Forecasts (V,U, W, L)
  • 5.5 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030
    • 5.5.1 Global Biologics Market for Hematological Disorders Segment: Recovery Forecasts (V,U, W, L)
  • 5.6 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030
    • 5.6.1 Global Biologics Market for Others Segment: Recovery Forecasts (V,U, W, L)

6 Global Biologics Market Size Forecast 2020-2030 by Manufacturing

  • 6.1 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030
    • 6.1.1 Global Biologics Market for Outsourced Manufacturing Segment: Recovery Forecasts (V,U, W, L)
  • 6.2 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030
    • 6.2.1 Global Biologics Market for In-house Manufacturing Segment: Recovery Forecasts (V,U, W, L)

7 Regional and Leading National Biologics Market Forecasts 2020-2030

  • 7.1 Global Biologics Market by National Market Forecast 2020-2030
    • 7.1.1 Global Biologics Market Forecast 2020-2030, Recovery Scenarios

8 North America

  • 8.1 North America Biologics Market Forecast by Country, 2020-2030
  • 8.2 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
    • 8.2.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • 8.3 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
    • 8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • 8.4 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
    • 8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • 8.5 U.S. Biologics Market Forecast 2020-2030
    • 8.5.1 U.S. Biologics Market: Recovery Scenarios
  • 8.6 Canada Biologics Market Forecast 2020-2030
    • 8.6.1 Canada Biologics Market: Recovery Scenarios

9 Europe

  • 9.1 Europe Biologics Market Forecast by Country, 2020-2030
  • 9.2 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
    • 9.2.1 Recovery Scenarios (V, U, W, L) Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • 9.3 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
    • 9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • 9.4 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
    • 9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • 9.5 Germany Biologics Market Forecast 2020-2030
    • 9.5.1 Germany Biologics Market: Recovery Scenarios
  • 9.6 UK Biologics Market Forecast 2020-2030
    • 9.6.1 UK Biologics Market: Recovery Scenarios
  • 9.7 France Biologics Market Forecast 2020-2030
    • 9.7.1 France Biologics Market: Recovery Scenarios
  • 9.8 Italy Biologics Market Forecast 2020-2030
    • 9.8.1 Italy Biologics Market: Recovery Scenarios
  • 9.9 Spain Biologics Market Forecast 2020-2030
    • 9.9.1 Spain Biologics Market: Recovery Scenarios
  • 9.10 Russia Biologics Market Forecast 2020-2030
    • 9.10.1 Russia Biologics Market: Recovery Scenarios
  • 9.11 RoE Biologics Market Forecast 2020-2030
    • 9.11.1 RoE Biologics Market: Recovery Scenarios

10 Asia-Pacific

  • 10.1 Asia-Pacific Biologics Market Forecast by Country, 2020-2030
  • 10.2 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
    • 10.2.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • 10.3 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
    • 10.3.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • 10.4 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
    • 10.4.1 Recovery Scenarios (V, U, W, L): Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • 10.5 Japan Biologics Market Forecast 2020-2030
    • 10.5.1 Japan Biologics Market: Recovery Scenarios
  • 10.6 China Biologics Market Forecast 2020-2030
    • 10.6.1 China Biologics Market: Recovery Scenarios
  • 10.7 India Biologics Market Forecast 2020-2030
    • 10.7.1 India Biologics Market: Recovery Scenarios
  • 10.8 Australia Biologics Market Forecast 2020-2030
    • 10.8.1 Australia Biologics Market: Recovery Scenarios
  • 10.9 RoAP Biologics Market Forecast 2020-2030
    • 10.9.1 RoAP Biologics Market: Recovery Scenarios

11 Latin America

  • 11.1 Latin America Biologics Market Forecast by Country, 2020-2030
  • 11.2 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
    • 11.2.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • 11.3 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
    • 11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • 11.4 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
    • 11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • 11.5 Brazil Biologics Market Forecast 2020-2030
    • 11.5.1 Brazil Biologics Market: Recovery Scenarios
  • 11.6 Mexico Biologics Market Forecast 2020-2030
    • 11.6.1 Mexico Biologics Market: Recovery Scenarios
  • 11.7 RoLA Biologics Market Forecast 2020-2030
    • 11.7.1 RoLA Biologics Market: Recovery Scenarios

12 Middle East and Africa

  • 12.1 MEA Biologics Market Forecast by Country, 2020-2030
  • 12.2 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
    • 12.2.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • 12.3 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
    • 12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • 12.4 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
    • 12.4.1 Recovery Scenarios (V, U, W, L): Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • 12.5 GCC Biologics Market Forecast 2020-2030
    • 12.5.1 GCC Biologics Market: Recovery Scenarios
  • 12.6 South Africa Biologics Market Forecast 2020-2030
    • 12.6.1 South Africa Biologics Market: Recovery Scenarios
  • 12.7 RoMEA Biologics Market Forecast 2020-2030
    • 12.7.1 RoMEA Biologics Market: Recovery Scenarios

13 Leading Companies in the Biologics Market

  • 13.1 GlaxoSmithKline Plc
    • 13.1.1 GlaxoSmithKline Plc: Company Snapshot
    • 13.1.2 GlaxoSmithKline Plc: Company Overview
    • 13.1.3 GlaxoSmithKline Plc Financials, 2015-2019
    • 13.1.4 GlaxoSmithKline Plc: Product Portfolio
    • 13.1.5 GlaxoSmithKline Plc: Recent Developments
  • 13.2 Johnson & Johnson Services, Inc
    • 13.2.1 Johnson & Johnson Services, Inc: Company Snapshot
    • 13.2.2 Johnson & Johnson Services, Inc: Company Overview
    • 13.2.3 Johnson & Johnson Services, Inc Financials, 2015-2019
    • 13.2.4 Johnson & Johnson Services, Inc: Product Portfolio
    • 13.2.5 Johnson & Johnson Services, Inc: Recent Developments
  • 13.3 Merck & Co
    • 13.3.1 Merck & Co: Company Snapshot
    • 13.3.2 Merck & Co: Company Overview
    • 13.3.3 Merck & Co Financials, 2015-2019
    • 13.3.4 Merck & Co: Product Portfolio
    • 13.3.5 Merck & Co: Recent Developments
  • 13.4 Novartis AG
    • 13.4.1 Novartis AG: Company Snapshot
    • 13.4.2 Novartis AG: Company Overview
    • 13.4.3 Novartis AG Financials, 2015-2019
    • 13.4.4 Novartis AG: Product Portfolio
    • 13.4.5 Novartis AG: Recent Developments
  • 13.5 Pfizer Inc
    • 13.5.1 Pfizer Inc: Company Snapshot
    • 13.5.2 Pfizer Inc: Company Overview
    • 13.5.3 Pfizer Inc Financials, 2015-2019
    • 13.5.4 Pfizer Inc: Product Portfolio
    • 13.5.5 Pfizer Inc: Recent Developments
  • 13.6 Sanofi S.A
    • 13.6.1 Sanofi S.A: Company Snapshot
    • 13.6.2 Sanofi S.A: Company Overview
    • 13.6.3 Sanofi S.A Financials, 2015-2019
    • 13.6.4 Sanofi S.A: Product Portfolio
    • 13.6.5 Sanofi S.A: Recent Developments
  • 13.7 Novo Nordisk A/S
    • 13.7.1 Novo Nordisk A/S: Company Snapshot
    • 13.7.2 Novo Nordisk A/S: Company Overview
    • 13.7.3 Novo Nordisk A/S Financials, 2015-2019
    • 13.7.4 Novo Nordisk A/S: Product Portfolio
    • 13.7.5 Novo Nordisk A/S: Recent Developments
  • 13.8 Takeda Pharmaceutical
    • 13.8.1 Takeda Pharmaceutical: Company Snapshot
    • 13.8.2 Takeda Pharmaceutical: Company Overview
    • 13.8.3 Takeda Pharmaceutical Financials, 2015-2019
    • 13.8.4 Takeda Pharmaceutical: Product Portfolio
    • 13.8.5 Takeda Pharmaceutical: Recent Developments
  • 13.9 Gilead Sciences Inc
    • 13.9.1 Gilead Sciences Inc: Company Snapshot
    • 13.9.2 Gilead Sciences Inc: Company Overview
    • 13.9.3 Gilead Sciences Inc Financials, 2015-2019
    • 13.9.4 Gilead Sciences Inc: Product Portfolio
    • 13.9.5 Gilead Sciences Inc: Recent Developments
  • 13.10 Alexion Pharmaceuticals, Inc
    • 13.10.1 Alexion Pharmaceuticals, Inc: Company Snapshot
    • 13.10.2 Alexion Pharmaceuticals, Inc: Company Overview
    • 13.10.3 Alexion Pharmaceuticals, Inc Financials, 2015-2019
    • 13.10.4 Alexion Pharmaceuticals, Inc: Product Portfolio
    • 13.10.5 Alexion Pharmaceuticals, Inc: Recent Developments
  • 13.11 UCB SA
    • 13.11.1 UCB SA: Company Snapshot
    • 13.11.2 UCB SA: Company Overview
    • 13.11.3 UCB SA Financials, 2015-2019
    • 13.11.4 UCB SA: Product Portfolio
    • 13.11.5 UCB SA: Recent Developments
  • 13.12 Samsung Biologics Co., Ltd
    • 13.12.1 Samsung Biologics Co., Ltd: Company Snapshot
    • 13.12.2 Samsung Biologics Co., Ltd: Company Overview
    • 13.12.3 Samsung Biologics Co., Ltd Financials, 2015-2019
    • 13.12.4 Samsung Biologics Co., Ltd: Product Portfolio
    • 13.12.5 Samsung Biologics Co., Ltd: Recent Developments
  • 13.13 NEKTAR THERAPEUTICS
    • 13.13.1 NEKTAR THERAPEUTICS: Company Snapshot
    • 13.13.2 NEKTAR THERAPEUTICS: Company Overview
    • 13.13.3 NEKTAR THERAPEUTICS Inc. Financials, 2015-2019
    • 13.13.4 NEKTAR THERAPEUTICS: Product Portfolio
    • 13.13.5 NEKTAR THERAPEUTICS: Recent Developments
  • 13.14 REGENERON PHARMACEUTICALS, INC.
    • 13.14.1 REGENERON PHARMACEUTICALS, INC.: Company Snapshot
    • 13.14.2 REGENERON PHARMACEUTICALS, INC.: Company Overview
    • 13.14.3 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019
    • 13.14.4 REGENERON PHARMACEUTICALS, INC.: Product Portfolio
    • 13.14.5 REGENERON PHARMACEUTICALS, INC.: Recent Developments
  • 13.15 BioMarin PHARMACEUTICALS, INC.
    • 13.15.1 BioMarin PHARMACEUTICALS, INC.: Company Snapshot
    • 13.15.2 BioMarin PHARMACEUTICALS, INC.: Company Overview
    • 13.15.3 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019
    • 13.15.4 BioMarin PHARMACEUTICALS, INC.: Product Portfolio
    • 13.15.5 BioMarin PHARMACEUTICALS, INC.: Recent Developments
  • 13.16 Biogen Inc.
    • 13.16.1 Biogen Inc.: Company Snapshot
    • 13.16.2 Biogen Inc.: Company Overview
    • 13.16.3 Biogen Inc. Financials, 2015-2019
    • 13.16.4 Biogen Inc.: Product Portfolio
    • 13.16.5 Biogen Inc.: Recent Developments
  • 13.17 BRISTOL-MYERS SQUIBB
    • 13.17.1 BRISTOL-MYERS SQUIBB: Company Snapshot
    • 13.17.2 BRISTOL-MYERS SQUIBB: Company Overview
    • 13.17.3 BRISTOL-MYERS SQUIBB Financials, 2015-2019
    • 13.17.4 BRISTOL-MYERS SQUIBB: Product Portfolio
    • 13.17.5 BRISTOL-MYERS SQUIBB: Recent Developments
  • 13.18 Biocon
    • 13.18.1 Biocon: Company Snapshot
    • 13.18.2 Biocon: Company Overview
    • 13.18.3 Biocon Financials, 2015-2019
    • 13.18.4 Biocon: Product Portfolio
    • 13.18.5 Biocon: Recent Developments
  • 13.19 Abbvie Inc
    • 13.19.1 Abbvie Inc: Company Snapshot
    • 13.19.2 Abbvie Inc: Company Overview
    • 13.19.3 Abbvie Inc Financials, 2015-2019
    • 13.19.4 Abbvie Inc: Product Portfolio
    • 13.19.5 Abbvie Inc: Recent Developments
  • 13.20 Amgen
    • 13.20.1 Amgen: Company Snapshot
    • 13.20.2 Amgen: Company Overview
    • 13.20.3 Amgen Financials, 2015-2019
    • 13.20.4 Amgen: Product Portfolio
    • 13.20.5 Amgen: Recent Developments
  • 13.21 AstraZeneca PLC
    • 13.21.1 AstraZeneca PLC: Company Snapshot
    • 13.21.2 AstraZeneca PLC: Company Overview
    • 13.21.3 AstraZeneca PLC Financials, 2015-2019
    • 13.21.4 AstraZeneca PLC: Product Portfolio
    • 13.21.5 AstraZeneca PLC: Recent Developments
  • 13.22 Eli Lilly
    • 13.22.1 Eli Lilly: Company Snapshot
    • 13.22.2 Eli Lilly: Company Overview
    • 13.22.3 Eli Lilly Financials, 2015-2019
    • 13.22.4 Eli Lilly: Product Portfolio
  • 13.23 F. Hoffmann-La Roche Ltd
    • 13.23.1 F. Hoffmann-La Roche Ltd: Company Snapshot
    • 13.23.2 F. Hoffmann-La Roche Ltd: Company Overview
    • 13.23.3 F. Hoffmann-La Roche Ltd Financials, 2015-2019
    • 13.23.4 F. Hoffmann-La Roche Ltd: Product Portfolio
    • 13.23.5 F. Hoffmann-La Roche Ltd: Recent Developments
  • 13.24 ANAPTYSBIO, INC.
    • 13.24.1 ANAPTYSBIO, INC.: Company Snapshot
    • 13.24.2 ANAPTYSBIO, INC.: Company Overview
    • 13.24.3 ANAPTYSBIO, INC. Financials, 2015-2019
    • 13.24.4 ANAPTYSBIO, INC.: Product Portfolio
    • 13.24.5 ANAPTYSBIO, INC.: Recent Developments

14 Conclusions

  • 14.1 Leading Products in 2020
  • 14.2 Leading Applications in 2020
  • 14.3 Leading Manufacturing Type in 2020
  • 14.4 Major Revenue Pockets to Look Out For
  • 14.5 Biologics Market to Achieve Steady Growth Throughout the Forecast Period
  • 14.6 Changes in Market Composition: mAbs to Become Leading Submarket
  • 14.7 The Emergence of Biosimilars
  • 14.8 Challenges for the Market

15 Glossary

List of Tables

  • Table 1 "V" Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 2 "U" Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 3 "W" Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 4 "L" Shaped Recovery: Global Biologics Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 5 Global Biologics Market, 2020-2030 (US$ billion, CAGR %)
  • Table 6 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 7 Regions of an Antibody
  • Table 8 Natural Antibody Mechanisms of Action
  • Table 9 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 10 "V" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 11 "U" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 12 "W" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 13 "L" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 14 Conditions Treated
  • Table 15 Selected Biosimilar Adalimumab Candidates
  • Table 16 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 17 "V" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 18 "U" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 19 "W" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 20 "L" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 21 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 22 "V" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 23 "U" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 24 "W" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 25 "L" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 26 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 27 "V" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 28 "U" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 29 "W" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 30 "L" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 31 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 32 "V" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 33 "U" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 34 "W" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 35 "L" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 36 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 37 "V" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 38 "U" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 39 "W" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 40 "L" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 41 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 42 "V" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 43 "U" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 44 "W" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 45 "L" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 46 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 47 "V" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 48 "U" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 49 "W" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 50 "L" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 51 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 52 "V" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 53 "U" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 54 "W" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 55 "L" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 56 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 57 "V" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 58 "U" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 59 "W" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 60 "L" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 61 FDA-Approved Indications for Cyramza
  • Table 62 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 63 "V" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 64 "U" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 65 "W" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 66 "L" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 67 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 68 "V" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 69 "U" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 70 "W" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 71 "L" Shaped Recovery: Global Biologics Systems Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 72 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 73 "V" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 74 "U" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 75 "W" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 76 "L" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 77 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 78 "V" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 79 "U" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 80 "W" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 81 "L" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 82 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 83 "V" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 84 "U" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 85 "W" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 86 "L" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 87 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 88 "V" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 89 "U" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 90 "W" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 91 "L" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 92 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 93 "V" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 94 "U" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 95 "W" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 96 "L" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 97 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 98 "V" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 99 "U" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 100 "W" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 101 "L" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 102 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 103 "V" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 104 "U" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 105 "W" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 106 "L" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 107 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 108 "V" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 109 "U" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 110 "W" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 111 "L" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 112 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 113 "V" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 114 "U" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 115 "W" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 116 "L" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 117 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 118 "V" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 119 "U" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 120 "W" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 121 "L" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 122 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 123 "V" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 124 "U" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 125 "W" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 126 "L" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 127 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 128 "V" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 129 "U" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 130 "W" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 131 "L" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 132 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 133 "V" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 134 "U" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 135 "W" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 136 "L" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 137 Potency and Source of Stem Cells
  • Table 138 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 139 "V" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 140 "U" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 141 "W" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 142 "L" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 143 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 144 "V" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 145 "U" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 146 "W" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 147 "L" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 148 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 149 "V" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 150 "U" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 151 "W" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 152 "L" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 153 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 154 "V" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 155 "U" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 156 "W" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 157 "L" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 158 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 159 "V" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 160 "U" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 161 "W" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 162 "L" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 163 "V" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 164 "U" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 165 "W" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 166 "L" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 167 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 168 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 169 "V" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 170 "U" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 171 "W" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 172 "L" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 173 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 174 "V" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 175 "U" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 176 "W" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 177 "L" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 178 Amgen's US Patents and Expiry Dates for Enbrel
  • Table 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 180 "V" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 181 "U" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 182 "W" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 183 "L" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 185 "V" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 186 "U" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 187 "W" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 188 "L" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 190 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 191 "V" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 192 "U" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 193 "W" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 194 "L" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 195 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 196 "V" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 197 "U" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 198 "W" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 199 "L" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 200 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 201 "V" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 202 "U" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 203 "W" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 204 "L" Shaped Recovery: Global Biologics Systems Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 205 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 206 "V" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 207 "U" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 208 "W" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 209 "L" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 210 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 211 "V" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 212 "U" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 213 "W" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 214 "L" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 215 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 216 "V" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 217 "U" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 218 "W" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 219 "L" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 220 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 221 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 222 "V" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 223 "U" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 224 "W" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 225 "L" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 226 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 227 "V" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 228 "U" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 229 "W" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 230 "L" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%)
  • Table 231 Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
  • Table 232 "V" Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
  • Table 233 "U" Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
  • Table 234 "W" Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
  • Table 235 "L" Shaped Recovery: Global Biologics Market Forecast by Region, 2020-2030 (US$ Billion, AGR %)
  • Table 236 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 237 "V" Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 238 "U" Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 239 "W" Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 240 "L" Shaped Recovery: North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 241 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 242 "V" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 243 "U" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 244 "W" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 245 "L" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 246 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 247 "V" Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 248 "U" Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 249 "W" Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 250 "L" Shaped Recovery: North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 251 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 252 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 253 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 254 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 255 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 256 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 257 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 258 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 259 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 260 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 261 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 262 "V" Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 263 "U" Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 264 "W" Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 265 "L" Shaped Recovery: Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 266 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 267 "V" Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 268 "U" Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 269 "W" Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 270 "L" Shaped Recovery: Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 271 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 272 "V" Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 273 "U" Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 274 "W" Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 275 "L" Shaped Recovery: Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 276 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 277 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 278 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 279 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 280 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 281 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 282 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 283 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 284 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 285 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 286 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 287 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 288 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 289 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 290 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 291 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 292 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 293 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 294 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 295 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 296 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 297 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 298 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 299 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 300 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 301 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 302 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 303 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 304 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 305 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 306 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 307 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 308 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 309 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 310 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 311 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 312 "V" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 313 "U" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 314 "W" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 315 "L" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 316 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 317 "V" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 318 "U" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 319 "W" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 320 "L" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 321 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 322 "V" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 323 "U" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 324 "W" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 325 "L" Shaped Recovery: Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 326 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 327 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 328 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 329 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 330 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 331 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 332 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 333 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 334 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 335 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 336 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 337 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 338 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 339 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 340 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 341 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 342 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 343 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 344 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 345 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 346 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 347 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 348 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 349 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 350 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 351 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 352 "V" Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 353 "U" Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 354 "W" Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 355 "L" Shaped Recovery: Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 356 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 357 "V" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 358 "U" Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 359 "W" Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 360 "L" Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 361 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 362 "V" Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 363 "U" Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 364 "W" Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 365 "L" Shaped Recovery: Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 366 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 367 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 368 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 369 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 370 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 371 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 372 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 373 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 374 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 375 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 376 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 377 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 378 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 379 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 380 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 381 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 382 "V" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 383 "U" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 384 "W" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 385 "L" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR %)
  • Table 386 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 387 "V" Shaped Recovery: North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 388 "U" Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 389 "W" Shaped Recovery: Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 390 "L" Shaped Recovery: MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR %)
  • Table 391 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 392 "V" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 393 "U" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 394 "W" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 395 "L" Shaped Recovery: Middle East & Africa Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Table 396 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 397 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 398 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 399 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 400 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 401 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 402 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 403 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 404 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 405 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 406 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %, CAGR %)
  • Table 407 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): V-Shaped Recovery
  • Table 408 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): U-Shaped Recovery
  • Table 409 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): W-Shaped Recovery
  • Table 410 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%, CAGR%): L-Shaped Recovery
  • Table 411 GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 412 GlaxoSmithKline Plc Product Portfolio
  • Table 413 GlaxoSmithKline Plc: Recent Developments
  • Table 414 Johnson & Johnson Services, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 415 Johnson & Johnson Services, Inc Product Portfolio
  • Table 416 Johnson & Johnson Services, Inc: Recent Developments
  • Table 417 Merck & Co Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 418 Merck & Co Product Portfolio
  • Table 419 Merck & Co: Recent Developments
  • Table 420 Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 421 Novartis AG Product Portfolio
  • Table 422 Novartis AG: Recent Developments
  • Table 423 Pfizer Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 424 Pfizer Inc Product Portfolio
  • Table 425 Pfizer Inc: Recent Developments
  • Table 426 Sanofi S.A Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 427 Sanofi S.A Product Portfolio
  • Table 428 Sanofi S.A: Recent Developments
  • Table 429 Novo Nordisk A/S Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 430 Novo Nordisk A/S Product Portfolio
  • Table 431 Novo Nordisk A/S: Recent Developments
  • Table 432 Takeda Pharmaceutical Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 433 Takeda Pharmaceutical Product Portfolio
  • Table 434 Takeda Pharmaceutical: Recent Developments
  • Table 435 Gilead Sciences Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 436 Gilead Sciences Inc Product Portfolio
  • Table 437 Gilead Sciences Inc: Recent Developments
  • Table 438 Alexion Pharmaceuticals, Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 439 Alexion Pharmaceuticals, Inc Product Portfolio
  • Table 440 Alexion Pharmaceuticals, Inc: Recent Developments
  • Table 441 UCB SA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 442 UCB SA Product Portfolio
  • Table 443 UCB SA: Recent Developments
  • Table 444 Samsung Biologics Co., Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 445 Samsung Biologics Co., Ltd Product Portfolio
  • Table 446 Samsung Biologics Co., Ltd: Recent Developments
  • Table 447 NEKTAR THERAPEUTICS Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 448 NEKTAR THERAPEUTICS Product Portfolio
  • Table 449 NEKTAR THERAPEUTICS: Recent Developments
  • Table 450 REGENERON PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 451 REGENERON PHARMACEUTICALS, INC. Product Portfolio
  • Table 452 REGENERON PHARMACEUTICALS, INC.: Recent Developments
  • Table 453 BioMarin PHARMACEUTICALS, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 454 BioMarin PHARMACEUTICALS, INC.: Recent Developments
  • Table 455 Biogen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 456 Biogen Inc. Product Portfolio
  • Table 457 Biogen Inc.: Recent Developments
  • Table 458 BRISTOL-MYERS SQUIBB Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 459 BRISTOL-MYERS SQUIBB Product Portfolio
  • Table 460 BRISTOL-MYERS SQUIBB: Recent Developments
  • Table 461 Biocon Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 462 Biocon Product Portfolio
  • Table 463 Biocon: Recent Developments
  • Table 464 Abbvie Inc Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 465 Abbvie Inc Product Portfolio
  • Table 466 Abbvie Inc: Recent Developments
  • Table 467 Amgen Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 468 Amgen Product Portfolio
  • Table 469 Amgen: Recent Developments
  • Table 470 AstraZeneca PLC Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 471 AstraZeneca PLC Product Portfolio
  • Table 472 AstraZeneca PLC: Recent Developments
  • Table 473 Eli Lilly Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 474 Eli Lilly Product Portfolio
  • Table 475 F. Hoffmann-La Roche Ltd Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 476 F. Hoffmann-La Roche Ltd Product Portfolio
  • Table 477 F. Hoffmann-La Roche Ltd: Recent Developments
  • Table 478 ANAPTYSBIO, INC. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 479 ANAPTYSBIO, INC. Product Portfolio
  • Table 480 ANAPTYSBIO, INC.: Recent Developments
  • Table 481 FDA Approved Biosimilars

List of Figures

  • Figure 1 Global Biologics Market Segmentation
  • Figure 2 "V" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 3 "U" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 4 "W" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 5 "L" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 6 Global Biologics Market Research Methodology: Top Down & Bottom Up Approach
  • Figure 7 Global Biologics Market Research Methodology: Data Triangulation
  • Figure 8 Global Biologics Market Overview
  • Figure 9 Porter's Five Forces Analysis
  • Figure 10 SWOT Analysis
  • Figure 11 PEST Analysis
  • Figure 12 Global Biologics Market Forecast by Product Type, 2020-2030 (US$ billion, AGR %)
  • Figure 13 Global Biologics Market Share Forecast by Product Type, 2020, 2025, 2030 (%)
  • Figure 14 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 15 "V" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 16 "U" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 17 "W" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 18 "L" Shaped Recovery: Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 19 Global Biologics Market for Humira Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 20 "V" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 21 "U" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 22 "W" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 23 "L" Shaped Recovery: Global Biologics Market for Humira Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 24 Global Biologics Market for Remicade Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 25 "V" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 26 "U" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 27 "W" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 28 "L" Shaped Recovery: Global Biologics Market for Remicade Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 29 Global Biologics Market for Tysabri Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 30 "V" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 31 "U" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 32 "W" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 33 "L" Shaped Recovery: Global Biologics Market for Tysabri Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 34 Global Biologics Market for Avastin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 35 "V" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 36 "U" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 37 "W" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 38 "L" Shaped Recovery: Global Biologics Market for Avastin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 39 Global Biologics Market for Herceptin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 40 "V" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 41 "U" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 42 "W" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 43 "L" Shaped Recovery: Global Biologics Market for Herceptin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 44 Global Biologics Market for Kadcyla Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 45 "V" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 46 "U" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 47 "W" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 48 "L" Shaped Recovery: Global Biologics Market for Kadcyla Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 49 Global Biologics Market for Perjeta Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 50 "V" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 51 "U" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 52 "W" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 53 "L" Shaped Recovery: Global Biologics Market for Perjeta Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 54 Global Biologics Market for Opdivo Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 55 "V" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 56 "U" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 57 "W" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 58 "L" Shaped Recovery: Global Biologics Market for Opdivo Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 59 Global Biologics Market for Keytruda Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 60 "V" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 61 "U" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 62 "W" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 63 "L" Shaped Recovery: Global Biologics Market for Keytruda Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 64 Global Biologics Market for Vaccines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 65 "V" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 66 "U" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 67 "W" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 68 "L" Shaped Recovery: Global Biologics Market for Vaccines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 69 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 70 "V" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 71 "U" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 72 "W" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 73 "L" Shaped Recovery: Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 74 Global Biologics Market for Insulin Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 75 "V" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 76 "U" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 77 "W" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 78 "L" Shaped Recovery: Global Biologics Market for Insulin Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 79 Global Biologics Market for Lantus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 80 "V" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 81 "U" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 82 "W" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 83 "L" Shaped Recovery: Global Biologics Market for Lantus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 84 Global Biologics Market for Novolog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 85 "V" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 86 "U" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 87 "W" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 88 "L" Shaped Recovery: Global Biologics Market for Novolog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 89 Global Biologics Market for Humalog Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 90 "V" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 91 "U" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 92 "W" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 93 "L" Shaped Recovery: Global Biologics Market for Humalog Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 94 Global Biologics Market for Levemir Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 95 "V" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 96 "U" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 97 "W" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 98 "L" Shaped Recovery: Global Biologics Market for Levemir Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 99 Global Biologics Market for Apidra Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 100 "V" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 101 "U" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 102 "W" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 103 "L" Shaped Recovery: Global Biologics Market for Apidra Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 104 Global Biologics Market for Other Recombinant Hormones Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 105 "V" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 106 "U" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 107 "W" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 108 "L" Shaped Recovery: Global Biologics Market for Other Recombinant Hormones Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 109 Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 110 "V" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 111 "U" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 112 "W" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 113 "L" Shaped Recovery: Global Biologics Market for Plasma and Recombinant Coagulating Factors Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 114 Global Biologics Market for Interferons Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 115 "V" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 116 "U" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 117 "W" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 118 "L" Shaped Recovery: Global Biologics Market for Interferons Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 119 Global Biologics Market for Avonex Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 120 "V" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 121 "U" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 122 "W" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 123 "L" Shaped Recovery: Global Biologics Market for Avonex Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 124 Global Biologics Market for Rebif Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 125 "V" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 126 "U" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 127 "W" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 128 "L" Shaped Recovery: Global Biologics Market for Rebif Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 129 Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 130 "V" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 131 "U" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 132 "W" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 133 "L" Shaped Recovery: Global Biologics Market for Enzyme Replacement & Other Protein Therapies Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 134 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 135 "V" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 136 "U" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 137 "W" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 138 "L" Shaped Recovery: Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 139 Global Biologics Market for Stem Cell Therapy Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 140 "V" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 141 "U" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 142 "W" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 143 "L" Shaped Recovery: Global Biologics Market for Stem Cell Therapy Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 144 Global Biologics Market for Osteocel Plus Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 145 "V" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 146 "U" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 147 "W" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 148 "L" Shaped Recovery: Global Biologics Market for Osteocel Plus Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 149 Global Biologics Market for Trinity Evolution & Trinity Elite Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 150 "V" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 151 "U" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 152 "W" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 153 "L" Shaped Recovery: Global Biologics Market for Trinity Evolution & Trinity Elite Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 154 Global Biologics Market for Tissue Engineered Products Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 155 "V" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 156 "U" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 157 "W" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 158 "L" Shaped Recovery: Global Biologics Market for Tissue Engineered Products Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 159 Global Biologics Market for Apligraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 160 "V" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 161 "U" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 162 "W" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 163 "L" Shaped Recovery: Global Biologics Market for Dermagraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 164 "V" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 165 "U" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 166 "W" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 167 "L" Shaped Recovery: Global Biologics Market for Apligraft Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 168 Global Biologics Market for Dermagraft Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 169 Global Biologics Market for IMIGYLC Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 170 "V" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 171 "U" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 172 "W" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 173 "L" Shaped Recovery: Global Biologics Market for IMIGYLC Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 174 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 175 "V" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 176 "U" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 177 "W" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 178 "L" Shaped Recovery: Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 179 Global Biologics Market for Enbrel Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 180 "V" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 181 "U" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 182 "W" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 183 "L" Shaped Recovery: Global Biologics Market for Enbrel Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 184 Global Biologics Market for Eylea Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 185 "V" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 186 "U" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 187 "W" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 188 "L" Shaped Recovery: Global Biologics Market for Eylea Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 189 Global Biologics Market Forecast by Application Type, 2020-2030 (US$ Billion, AGR %)
  • Figure 190 Global Biologics Market Share Forecast by Application Type, 2020, 2025, 2030 (%)
  • Figure 191 Global Biologics Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 192 "V" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 193 "U" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 194 "W" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 195 "L" Shaped Recovery: Global Biologics Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 196 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 197 "V" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 198 "U" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 199 "W" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 200 "L" Shaped Recovery: Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 201 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 202 "V" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 203 "U" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 204 "W" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 205 "L" Shaped Recovery: Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 206 Global Biologics Market for Cardiovascular Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 207 "V" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 208 "U" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 209 "W" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 210 "L" Shaped Recovery: Global Biologics Market for Cardiovascular Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 211 Global Biologics Market for Hematological Disorders Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 212 "V" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 213 "U" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 214 "W" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 215 "L" Shaped Recovery: Global Biologics Market for Hematological Disorders Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 216 Global Biologics Market for Others Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 217 "V" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 218 "U" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 219 "W" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 220 "L" Shaped Recovery: Global Biologics Market for Others Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 221 Global Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR %)
  • Figure 222 Global Biologics Market Share Forecast by Manufacturing, 2020, 2025, 2030 (%)
  • Figure 223 Global Biologics Market for Outsourced Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 224 "V" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 225 "U" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 226 "W" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 227 "L" Shaped Recovery: Global Biologics Market for Outsourced Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 228 Global Biologics Market for In-house Manufacturing Segment: Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 229 "V" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 230 "U" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 231 "W" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 232 "L" Shaped Recovery: Global Biologics Market for In-house Manufacturing Segment, Revenue Forecast 2020-2030 (US$ Billion, AGR%)
  • Figure 233 Global Biologics Market Forecast by Region 2020-2030 (US$ Billion)
  • Figure 234 Global Biologics Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 235 North America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
  • Figure 236 North America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 237 North America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • Figure 238 North America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • Figure 239 North America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • Figure 240 U.S. Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 241 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 242 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 243 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 244 U.S. Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 245 Canada Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 246 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 247 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 248 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 249 Canada Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 250 Europe Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
  • Figure 251 Europe Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 252 Europe Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • Figure 253 Europe Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • Figure 254 Europe Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • Figure 255 Germany Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 256 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 257 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 258 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 259 Germany Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 260 UK Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 261 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 262 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 263 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 264 UK Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 265 France Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 266 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 267 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 268 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 269 France Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 270 Italy Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 271 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 272 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 273 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 274 Italy Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 275 Spain Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 276 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 277 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 278 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 279 Spain Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 280 Russia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 281 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 282 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 283 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 284 Russia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 285 RoE Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 286 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 287 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 288 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 289 RoE Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 290 Asia-Pacific Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
  • Figure 291 Asia-Pacific Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 292 Asia-Pacific Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • Figure 293 Asia-Pacific Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • Figure 294 Asia-Pacific Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • Figure 295 Japan Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 296 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 297 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 298 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 299 Japan Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 300 China Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 301 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 302 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 303 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 304 China Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 305 India Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 306 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 307 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 308 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 309 India Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 310 Australia Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 311 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 312 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 313 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 314 Australia Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 315 RoAP Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 316 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 317 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 318 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 319 RoAP Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 320 Latin America Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
  • Figure 321 Latin America Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 322 Latin America Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • Figure 323 Latin America Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • Figure 324 Latin America Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • Figure 325 Brazil Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 326 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 327 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 328 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 329 Brazil Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 330 Mexico Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 331 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 332 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 333 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 334 Mexico Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 335 RoLA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 336 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 337 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 338 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 339 RoLA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 340 MEA Biologics Market Forecast by Country, 2020-2030 (US$ Billion)
  • Figure 341 MEA Biologics Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 342 MEA Biologics Market Forecast by Product Type, 2020-2030 (US$ Billion, AGR%)
  • Figure 343 MEA Biologics Market Forecast by Application, 2020-2030 (US$ Billion, AGR%)
  • Figure 344 MEA Biologics Market Forecast by Manufacturing, 2020-2030 (US$ Billion, AGR%)
  • Figure 345 GCC Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 346 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 347 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 348 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 349 GCC Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 350 South Africa Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 351 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 352 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 353 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 354 South Africa Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 355 RoMEA Biologics Market Forecast 2020-2030 (US$ Billion, AGR %)
  • Figure 356 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): V-Shaped Recovery
  • Figure 357 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): U-Shaped Recovery
  • Figure 358 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): W-Shaped Recovery
  • Figure 359 RoMEA Biologics Market, Revenue Forecast 2020-2030 (US$ Billion, AGR%): L-Shaped Recovery
  • Figure 360 Biologics Market for Monoclonal Antibodies: Company Share Analysis (%), 2019
  • Figure 361 GlaxoSmithKline Plc Financials, 2015-2019 (US$ million, AGR %)
  • Figure 362 Johnson & Johnson Financials, 2015-2019 (US$ million
  • Figure 363 Merck & Co Financials, 2015-2019 (US$ million, AGR %)
  • Figure 364 Novartis AG Financials, 2015-2019 (US$ million, AGR %)
  • Figure 365 Pfizer Inc Financials, 2015-2019 (US$ million, AGR %)
  • Figure 366 Sanofi S.A Financials, 2015-2019 (US$ million, AGR %)
  • Figure 367 Novo Nordisk A/S Financials, 2015-2019 (US$ million, AGR %)
  • Figure 368 Takeda Pharmaceutical Financials, 2015-2019 (US$ million, AGR %)
  • Figure 369 Gilead Sciences Inc Financials, 2015-2019 (US$ million, AGR %)
  • Figure 370 Alexion Pharmaceuticals, Inc Financials, 2015-2019 (US$ million, AGR %)
  • Figure 371 UCB SA Financials, 2015-2019 (US$ million, AGR %)
  • Figure 372 Samsung Biologics Co., Ltd Financials, 2015-2019 (US$ million, AGR %)
  • Figure 373 NEKTAR THERAPEUTICS Financials, 2015-2019 (US$ million, AGR %)
  • Figure 374 REGENERON PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
  • Figure 375 BioMarin PHARMACEUTICALS, INC. Financials, 2015-2019 (US$ million, AGR %)
  • Figure 376 Biogen Inc. Financials, 2015-2019 (US$ million, AGR %)
  • Figure 377 BRISTOL-MYERS SQUIBB Financials, 2015-2019 (US$ Million, AGR %)
  • Figure 378 Biocon Financials, 2015-2019 (US$ Million, AGR %)
  • Figure 379 Abbvie Inc Financials, 2015-2019 (US$ million, AGR %)
  • Figure 380 Amgen Financials, 2015-2019 (US$ million, AGR %)
  • Figure 381 AstraZeneca PLC Financials, 2015-2019 (US$ million, AGR %)
  • Figure 382 Eli Lilly Financials, 2015-2019 (US$ million, AGR %)
  • Figure 383 F. Hoffmann-La Roche Ltd Financials, 2015-2019 (US$ million, AGR %)
  • Figure 384 ANAPTYSBIO, INC. Financials, 2015-2019 (US$ million, AGR %)

Companies Listed:

  • Abbvie Inc
  • Adaptive Biotechnologies
  • Alexion Pharmaceuticals, Inc
  • Allergan
  • Amgen
  • Anaptysbio, Inc.
  • Array BioPharma Inc.
  • AstraZeneca PLC
  • Bevespi Aerosphere
  • Biocon
  • Biogen Inc.
  • BioMarin Pharmaceuticals, Inc.
  • BioNTech SE
  • Bioverativ Inc.
  • Bluebird bio, Inc.
  • Bristol-Myers Squibb Premier
  • Clover Pharmaceuticals
  • Colorado Center for Personalized Medicine (CCPM)
  • Corvidia Therapeutics Inc.
  • Daiichi Sankyo
  • Denali Therapeutics Inc.
  • DiNAQOR AG
  • Eisai, Co., Ltd.
  • Eli Lilly
  • F. Hoffmann-La Roche Ltd
  • Food and Drug Administration
  • Frazier Healthcare Partners
  • Gilead Sciences Inc
  • GlaxoSmithKline plc
  • Health Canada
  • HitGen Inc.
  • Humanigen, Inc
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • Luye Pharma Group
  • Merck & Co
  • National Medical Products Administration (NMPA)
  • Nektar Therapeutics
  • Neurocrine Biosciences
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Portola Pharmaceuticals, Inc.
  • Q-State Biosciences
  • Regeneron Pharmaceuticals, Inc.
  • Rice University
  • Samsung Biologics Co., Ltd
  • Sangamo
  • Sanofi S.A
  • Spark Therapeutics , Inc.
  • Takeda Pharmaceutical
  • Tango Therapeutics
  • Teneobio, Inc.
  • TESARO, Inc
  • Therachon Holding AG,
  • UCB SA
  • United States Biologics License Application (BLA)
  • World Federation of Hemophilia (WFH)
  • Zai Lab Reveal
  • List of Organizations
  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • Australia's Walter and Eliza Hall Institute
  • Boston Children's Hospital
  • Center for Disease Prevention and Control (CDC)
  • Central Drugs Standard Control Organisation
  • China Food and Drug Administration
  • Duke University School of Medicine
  • EMA (European Medicines Agency)
  • European Commission (EC)
  • European Federation of Pharmaceutical Industries and Associations
  • Harvard University
  • Human Stem Cells Institute
  • International Myeloma Foundation
  • Johns Hopkins
  • Musculoskeletal Transplant Foundation (MTF)
  • National Cancer Institute
  • New York Blood Center
  • NHS
  • NICE
  • Rice University
  • Saudi Food and Drug Authority
  • SSN Cardinal Glennon Children's Medical Center
  • Stanford University
  • The European Generic medicines Association (EGA)
  • The European Group for Blood and Marrow Transplantation (EBMT)
  • The U.S. President's Emergency Plan for AIDS Relief (PEPFAR)
  • The University of Manchester
  • The University of Texas
  • The University of Texas MD Anderson Cancer Center
  • Toronto University
  • Toronto University
  • UCSF (University of California, San Francisco)
  • United Therapeutics
  • University of California, Berkeley
  • University of Colorado Cord Blood Bank
  • University of Tokyo
  • US Center for Disease Prevention and Control (CDC)
  • US Food and Drug Administration
  • Walter and Eliza Hall Institute
  • World Bank
  • World Health Organization (WHO)
Back to Top